Skip to content Skip to left sidebar Skip to right sidebar Skip to footer

Tag: #PatientSafety

Empowering Dialysis Professionals Through Continuous Medical Education

DCDC Kidney Care, in collaboration with Gandhi Medical College and Hospital, successfully organized a Continuing Medical Education (CME) programme in Hyderabad, reaffirming its commitment to advancing excellence in kidney care through continuous professional learning and skill development.

The programme witnessed enthusiastic participation from more than 200 dialysis technicians and nursing professionals representing healthcare institutions across Telangana. Designed as a comprehensive capacity-building initiative, the CME served as a valuable platform for frontline healthcare professionals to enhance their clinical expertise, update their knowledge on the latest advancements in nephrology, and strengthen best practices in dialysis management.

Dialysis technicians and nursing professionals play an indispensable role in the treatment journey of patients with chronic kidney disease. Their clinical competence, adherence to infection control protocols, patient monitoring skills, and commitment to quality care significantly influence patient safety and treatment outcomes. Recognizing this vital responsibility, the programme focused on equipping participants with evidence-based knowledge, practical insights, and the latest clinical guidelines to support the delivery of safe, effective, and patient-centric dialysis care.

The academic sessions were led by an esteemed panel of 14 nephrology experts and senior clinicians, who shared their expertise on a wide range of topics related to nephrology and dialysis. The distinguished faculty included Dr. Manjusha Yadla, Professor and Head of the Department of Nephrology, Dr. Shrinivas, and Dr. Srikanth, whose insightful presentations encouraged meaningful discussions and knowledge exchange among participants. The programme was also graced by the presence of Dr. Hariprasad, Head of the Department of Nephrology, District Hospital, Mahabubabad.

Throughout the day, participants engaged in interactive academic sessions covering advancements in dialysis techniques, patient safety protocols, infection prevention, vascular access management, emergency preparedness, quality improvement practices, and the evolving role of multidisciplinary teams in nephrology care. The sessions fostered collaborative learning and provided practical takeaways that healthcare professionals can implement in their daily clinical practice.

At DCDC Kidney Care, continuous education is an integral part of our mission to improve the quality of kidney care across India. By investing in the knowledge and skills of dialysis technicians and nursing professionals, we aim to strengthen the healthcare ecosystem, promote clinical excellence, and ensure better outcomes for every patient undergoing dialysis treatment.

We extend our sincere gratitude to Gandhi Medical College and Hospital, the distinguished faculty members, healthcare leaders, and every participant whose enthusiasm and commitment made this CME programme a resounding success. Together, we continue to build a stronger, more knowledgeable, and compassionate dialysis care community dedicated to transforming the lives of patients with kidney disease.

Together, we learn. Together, we grow. Together, we advance kidney care.

Doctors Unite to Support Hyderabad Paediatrician Amid Legal Threat Over ORS Advice

A wave of support is building across the medical community for a Hyderabad-based paediatrician, Dr. Sivaranjani Santosh, who is facing legal notices from pharmaceutical companies over her long-standing campaign on misleading ORS (Oral Rehydration Solution) products.

What Sparked the Controversy?

For nearly a decade, Dr. Sivaranjani has been raising concerns about high-sugar beverages being marketed as ORS, arguing that such products can be harmful—especially for children.

Recently, two pharmaceutical companies issued cease-and-desist notices, accusing her of making defamatory statements and demanding that she stop her public advocacy.

The companies, however, maintain that their products comply with regulatory standards and are backed by scientific evidence.

Medical Community Calls It “Intimidation”

The legal action has triggered strong reactions from doctors and healthcare organizations across the country.

Medical associations have described the notices as:

  • “Unwarranted”
  • An “attempt to intimidate” a doctor
  • A move that could silence public health advocacy

Many professionals argue that raising concerns about patient safety should not lead to legal threats, especially when backed by scientific reasoning and regulatory discussions.

Backed by Regulations and Public Support

Dr. Sivaranjani has defended her stance, stating that her claims are aligned with Food Safety and Standards Authority of India (FSSAI) directives, which restrict the misuse of the term “ORS” for non-compliant products.

Her years-long campaign even contributed to stricter regulations on labeling, highlighting the impact of sustained public health advocacy.

Meanwhile, support has extended beyond the medical community, with:

  • Social media campaigns like #StandWithDrSivaranjani
  • Backing from parents and public health advocates

A Bigger Debate: Public Health vs Legal Pressure

This issue has now grown into a broader debate about:

  • The role of doctors in public advocacy
  • Corporate accountability in healthcare
  • Whether legal notices can discourage professionals from speaking out

For many, the case represents a critical moment for medical freedom and patient safety.

Why This Matters

At its core, the controversy is not just about one doctor—it’s about whether health professionals can openly challenge practices they believe may harm patients.

As the debate continues, the strong support for Dr. Sivaranjani shows that the medical community is standing firm on one principle:
👉 Patient safety should always come first.